Gut microbial metabolite 4-cresol attenuates myocardial ischemia/reperfusion injury in diabetes
-
摘要:
目的 旨在研究4-甲酚对糖尿病(diabetic mellitus, DM)大鼠心肌缺血/再灌注(myocardial ischemia-reperfusion, MI/R)损伤的保护作用,并初步探讨其机制。 方法 取雄性SD大鼠,分为正常对照组和糖尿病组。利用高脂饲料联合链脲霉素诱导2型糖尿病大鼠模型。造模成功后,随即分为3组:糖尿病假手术组(DM+Sham)、糖尿病心肌缺血/再灌注组(DM+MI/R)和糖尿病心肌缺血/再灌注+4-甲酚组(DM+MI/R+4-cresol)。4-cresol组采用植入式胶囊渗透压泵给药(5.5 mmol/L 4-cresol,0.15 µL/h),其余给予生理盐水。6周后,采用结扎冠状动脉左前降支30 min再灌注3 h的方法建立心肌缺血/再灌注模型。再灌注结束处死大鼠,检测心肌梗死和细胞凋亡。检测心肌氧化应激程度。测定心肌双底物特异性酪氨酸磷酸化调节激酶1a(dual specificity tyrosine-phosphorylation-regulated kinase 1A, Dyrk1A)表达以及细胞凋亡信号调节激酶1(apoptosis signal-regulating kinase, ASK1)磷酸化水平。 结果 4-甲酚可有效减轻糖尿病大鼠心肌损伤,表现为心肌梗死面积下降、血清肌酸激酶(Ccreatine kinase, CK)及乳酸脱氢酶(Llactic dehydrogenase, LDH)活性降低、心肌细胞凋亡减少(P<0.05,P<0.01),同时4-甲酚显著抑制心肌丙二醛(malonic dialdehyde, MDA)含量(P<0.01),增加超氧化物歧化酶(superoxide Dismutase, SOD)含量、谷胱甘肽过氧化物酶(glutathione peroxidase, GSH-Px)含量(P<0.05,P<0.01),表明4-甲酚可以有效减轻氧化应激。此外,4-甲酚处理后,心肌Dyrk1A表达以及ASK1的磷酸化水平显著降低(P<0.05)。 结论 4-甲酚可显著减轻糖尿病大鼠心肌缺血/再灌注损伤,其具体机制与激活Dyrk1A信号,抑制氧化应激,减轻细胞凋亡相关。 Abstract:AIM To observe the protective effect of 4-cresol on diabetic hearts following ischemia/reperfusion (I/R) and to explore the possible molecular mechanisms. METHODS Forty-six male SD rats were randomly divided into normal control (CON) group and diabetes mellitus (DM) group. The DM rat model was induced by high-fat diet combined with a low-dose intraperitoneal injection of streptozotocin. Diabetic rats were randomly subdivided into three groups: Sham-operated DM rats (DM+Sham), DM+MI/R, and DM+MI/R+4-cresol (5.5 mmol/L 4-cresol, 0.15 µL/h). The MI/R model was established by coronary artery ligation. After 30 min of ischemia, the myocardium was reperfused for 3 h. RESULTS 4-cresol significantly attenuated myocardial injury in diabetes as evidenced by decreased infarct size, serum CK and LDH activities and cell apoptosis. Moreover, 4-cresol increased superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and decreased malonaldehyde (MDA) in I/R hearts (P<0.05, P<0.01). Additionally, 4-cresol supplementation markedly inhibited dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) expression and decreased the phosphorylation of apoptosis signal-regulating kinase 1 (ASK1) (P<0.05, P<0.01). CONCLUSION 4-cresol effectively inhibits Dyrk1A expression, reduces oxidative stress and cardiomyocyte apoptosis and eventually alleviates MI/R injury in diabetic hearts. -
Key words:
- 4-cresol /
- apoptosis /
- oxidative stress /
- diabetic heart /
- myocardial ischemia/reperfusion
-
-
[1] Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes[J]. JAMA, 2007, 298(7): 765 – 775. doi: 10.1001/jama.298.7.765 [2] Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes[J]. Circ Res, 2016, 118(11): 1808 – 1829. doi: 10.1161/CIRCRESAHA.116.306923 [3] Gonzalez-Montero J, Brito R, Gajardo AI, et al. Myocardial reperfusion injury and oxidative stress: therapeutic opportunities[J]. World J Cardiol, 2018, 10(9): 74 – 86. doi: 10.4330/wjc.v10.i9.74 [4] Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS[J]. Circulation, 2003, 108(16): 1912 – 1916. doi: 10.1161/01.CIR.0000093660.86242.BB [5] Brial F, Alzaid F, Sonomura K, et al. The natural metabolite 4-cresol improves glucose homeostasis and enhances beta-cell function[J]. Cell Rep, 2020, 30(7): 2306 – 2320,e5. doi: 10.1016/j.celrep.2020.01.066 [6] Bermudez-Martin P, Becker JAJ, Caramello N, et al. The microbial metabolite p-cresol induces autistic-like behaviors in mice by remodeling the gut microbiota[J]. Microbiome, 2021, 9(1): 157. doi: 10.1186/s40168-021-01103-z [7] Korytowska N, Wyczalkowska-Tomasik A, Wiśniewska A, et al. Development of the lc-ms/ms method for determining the p-cresol level in plasma[J]. J Pharm Biomed Anal, 2019, 167: 149 – 154. doi: 10.1016/j.jpba.2019.01.041 [8] Andersen A. Final report on the safety assessment of sodium p-chloro-m-cresol, p-chloro-m-cresol, chlorothymol, mixed cresols, m-cresol, o-cresol, p-cresol, isopropyl cresols, thymol, o-cymen-5-ol, and carvacrol[J]. Int J Toxicol, 2006, 25(Suppl 1): 29 – 127. doi: 10.1080/10915810600716653 [9] 王 勇, 焦晓臻. 双底物特异性酪氨酸磷酸化调节激酶1a及其抑制剂的研究进展[J]. 药物化学, 2020, 8(2): 38 – 50. doi: 10.12677/HJMCe.2020.82006 [10] Li Y, Xie X, Jie Z, et al. DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis[J]. Blood, 2021, 138(23): 2360 – 2371. doi: 10.1182/blood.2021011247 [11] Kumar K, Suebsuwong C, Wang P, et al. DYRK1A inhibitors as potential therapeutics for β-cell regeneration for diabetes[J]. J Med Chem, 2021, 64(6): 2901 – 2922. doi: 10.1021/acs.jmedchem.0c02050 [12] Obsilova V, Honzejkova K, Obsil T. Structural insights support targeting ASK1 kinase for therapeutic interventions[J]. Int J Mol Sci, 2021, 22(24): 13395. doi: 10.3390/ijms222413395 [13] Choi HK, Chung KC. Dyrk1A positively stimulates ask1-jnk signaling pathway during apoptotic cell death[J]. Exp Neurobiol, 2011, 20(1): 35 – 44. doi: 10.5607/en.2011.20.1.35 -